Centessa Pharmaceuticals Statistics
Total Valuation
CNTA has a market cap or net worth of $3.99 billion. The enterprise value is $3.86 billion.
Important Dates
The last earnings date was Wednesday, November 5, 2025, before market open.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CNTA has 146.08 million shares outstanding. The number of shares has increased by 25.82% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 146.08M |
| Shares Change (YoY) | +25.82% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 46.41% |
| Float | 84.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 242.72 |
| Forward PS | n/a |
| PB Ratio | 12.18 |
| P/TBV Ratio | 13.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 257.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.57, with a Debt / Equity ratio of 0.39.
| Current Ratio | 10.57 |
| Quick Ratio | 10.25 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.21 |
Financial Efficiency
Return on equity (ROE) is -60.62% and return on invested capital (ROIC) is -26.63%.
| Return on Equity (ROE) | -60.62% |
| Return on Assets (ROA) | -25.26% |
| Return on Invested Capital (ROIC) | -26.63% |
| Return on Capital Employed (ROCE) | -51.00% |
| Revenue Per Employee | $194,805 |
| Profits Per Employee | -$3.15M |
| Employee Count | 77 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CNTA has paid $3.39 million in taxes.
| Income Tax | 3.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +70.75% in the last 52 weeks. The beta is 1.57, so CNTA's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | +70.75% |
| 50-Day Moving Average | 23.36 |
| 200-Day Moving Average | 16.91 |
| Relative Strength Index (RSI) | 66.47 |
| Average Volume (20 Days) | 2,077,008 |
Short Selling Information
| Short Interest | 5.15M |
| Short Previous Month | 5.20M |
| Short % of Shares Out | 4.51% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.38 |
Income Statement
In the last 12 months, CNTA had revenue of $15.00 million and -$242.70 million in losses. Loss per share was -$1.82.
| Revenue | 15.00M |
| Gross Profit | 15.00M |
| Operating Income | -213.80M |
| Pretax Income | -239.31M |
| Net Income | -242.70M |
| EBITDA | -213.49M |
| EBIT | -213.80M |
| Loss Per Share | -$1.82 |
Full Income StatementBalance Sheet
The company has $246.21 million in cash and $118.26 million in debt, giving a net cash position of $127.96 million or $0.88 per share.
| Cash & Cash Equivalents | 246.21M |
| Total Debt | 118.26M |
| Net Cash | 127.96M |
| Net Cash Per Share | $0.88 |
| Equity (Book Value) | 301.57M |
| Book Value Per Share | 2.24 |
| Working Capital | 278.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$180.81 million and capital expenditures -$360,000, giving a free cash flow of -$181.17 million.
| Operating Cash Flow | -180.81M |
| Capital Expenditures | -360,000 |
| Free Cash Flow | -181.17M |
| FCF Per Share | -$1.24 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,425.33% |
| Pretax Margin | -1,595.38% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.82% |
| Shareholder Yield | -25.82% |
| Earnings Yield | -6.08% |
| FCF Yield | -4.54% |
Analyst Forecast
The average price target for CNTA is $32.25, which is 18.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.25 |
| Price Target Difference | 18.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CNTA has an Altman Z-Score of 4.29 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.29 |
| Piotroski F-Score | 2 |
